Human monoclonal antibodies to epidermal growth factor receptor
AssigneeAbgenix, Inc.
InventorsAya Jakobovits, Xiao-Dong Yang, Michael Gallo, Xiao-Chi Jia
Life of this patent
Estimating the term…
Abstract
In accordance with the present invention, there are provided fully human monoclonal antibodies against human epidermal growth factor receptor (EGF-r). Nucelotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences from CDR1 through CDR3, are provided. Hybridomas expressing such immunoglobulin molecules and monoclonal antibodies are also provided.
Claims16
An isolated antibody that is capable of binding epidermal growth factor receptor comprising a heavy chain variable region comprising a contiguous sequence from CDR1 through CDR3 as represented in SEQ ID NO:23.
An isolated antibody that is capable of binding epidermal growth factor receptor comprising a heavy chain variable region comprising a contiguous sequence from CDR1 through CDR3 as represented in SEQ ID NO:25.
An isolated antibody that is capable of binding epidermal growth factor receptor comprising a heavy chain variable region comprising a contiguous sequence from CDR1 through CDR3 as represented in SEQ ID NO:27.
An isolated antibody that is capable of binding epidermal growth factor receptor comprising a heavy chain variable region comprising a contiguous sequence from CDR1 through CDR3 as represented in SEQ ID NO:29.
An isolated antibody that is capable of binding epidermal growth factor receptor comprising a heavy chain variable region comprising a contiguous sequence from CDR1 through CDR3 as represented in SEQ ID NO:31.
An isolated antibody that is capable of binding epidermal growth factor receptor comprising a heavy chain variable region comprising a contiguous sequence from CDR1 through CDR3 as represented in SEQ ID NO:33.
An isolated antibody that is capable of binding epidermal growth factor receptor comprising a heavy chain variable region comprising a contiguous sequence from CDR1 through CDR3 as represented in SEQ ID NO:35.
An isolated antibody that is capable of binding epidermal growth factor receptor comprising a heavy chain variable region comprising a contiguous sequence from CDR1 through CDR3 as represented in SEQ ID NO:37.
Dependencies are inferred from the claim text.